These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15711757)

  • 1. The study of anaemia-related haemostasis impairment in haemodialysis patients by in vitro closure time test.
    Zupan IP; Sabovic M; Salobir B; Ponikvar JB; Cernelc P; Lavre J; Vujkovac B
    Thromb Haemost; 2005 Feb; 93(2):375-9. PubMed ID: 15711757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between platelet-related hemostasis impairment and functional iron deficiency in hemodialysis patients.
    Zupan IP; Sabovic M; Salobir B; Ponikvar JB; Cernelc P; Lavre J; Vujkovac B
    Ther Apher Dial; 2011 Feb; 15(1):34-9. PubMed ID: 21272250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of in vitro closure time test for evaluating platelet-related primary hemostasis in dialysis patients.
    Zupan IP; Sabovic M; Salobir B; Ponikvar JB; Cernelc P
    Am J Kidney Dis; 2003 Oct; 42(4):746-51. PubMed ID: 14520625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
    Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
    Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of haemostatic activity in haemodialysis and peritoneal dialysis patients with a novel technique, haemostatometry.
    Roger SD; Piper J; Tucker B; Raine AE; Baker LR; Kovacs IB
    Nephron; 1992; 62(4):422-8. PubMed ID: 1300438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis shortens long in vitro closure times as measured by the PFA-100.
    Bilgin AU; Karadogan I; Artac M; Kizilors A; Bligin R; Undar L
    Med Sci Monit; 2007 Mar; 13(3):CR141-5. PubMed ID: 17325638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of Trivé 1000 on hemostasis and hematocrit].
    Fogliani J; Siccardi F; Ruggieri F
    Ann Anesthesiol Fr; 1977; 18(2):214-22. PubMed ID: 18968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of abnormal in vitro closure time using the Platelet Function Analyzer-100 in chronic kidney disease patients and analysis of associated factors.
    Kim HJ; Kim KM; Koo TY; Chi HS; Kim SH; Kim SB
    Clin Nephrol; 2011 Sep; 76(3):195-200. PubMed ID: 21888856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
    Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
    Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stored erythrocytes have less capacity than normal erythrocytes to support primary haemostasis.
    Reinhart WH; Zehnder L; Schulzki T
    Thromb Haemost; 2009 Apr; 101(4):720-3. PubMed ID: 19350117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation.
    Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A
    Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of habitual physical activity in chronic haemodialysis patients.
    Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
    Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential use of desmopressin to correct hypothermia-induced impairment of primary haemostasis--an in vitro study using PFA-100.
    Ying CL; Tsang SF; Ng KF
    Resuscitation; 2008 Jan; 76(1):129-33. PubMed ID: 17714852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients.
    Sabovic M; Zupan IP; Salobir B; Zupan I; Cernelc P; Lavre J; Vujkovac B
    Thromb Haemost; 2005 Dec; 94(6):1245-50. PubMed ID: 16411401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the haematocrit on primary haemostasis in vitro.
    Eugster M; Reinhart WH
    Thromb Haemost; 2005 Dec; 94(6):1213-8. PubMed ID: 16411396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of anaemia with desferrioxamine in haemodialysis patients.
    Praga M; Andrés A; de la Serna J; Ruilope LM; Nieto J; Estenoz J; Millet VG; Arnaiz F; Rodicio JL
    Nephrol Dial Transplant; 1987; 2(4):243-7. PubMed ID: 3118265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reconfirmation of preanalytical variables and establishment of reference intervals of platelet function analyzer-100 closure times in Korean adults].
    Cho YU; Chi HS; Jang S; Park CJ
    Korean J Lab Med; 2007 Oct; 27(5):318-23. PubMed ID: 18094595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.